Recently Viewed
Clear All₹393.15
₹-14.00
(-3.44%)
As on 19-Mar-2026 11:49IST
Value Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹3,623 Cr
Revenue (TTM)
₹1,451 Cr
Net Profit (TTM)
₹183 Cr
ROE
30 %
ROCE
41.4 %
P/E Ratio
19.8
P/B Ratio
5.2
Industry P/E
44.5
EV/EBITDA
10.8
Div. Yield
1.1 %
Debt to Equity
0
Book Value
₹76.3
EPS
₹20
Face value
10
Shares outstanding
91,673,000
CFO
₹921.72 Cr
EBITDA
₹1,141.04 Cr
Net Profit
₹575.87 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Indraprastha Med
| -12.3 | -6.8 | -14.5 | 10.7 | 70.1 | 47.4 | 23.4 |
|
BSE Healthcare
| -3.3 | -3.0 | -3.3 | 3.8 | 24.9 | 15.6 | 10.6 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Indraprastha Med
| -17.3 | 192.9 | 107.5 | 9.1 | 32.8 | 41.5 | 0.4 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Indraprastha Med
|
393.2 | 3,623.4 | 1,451.5 | 182.9 | 15.5 | 29.2 | 19.8 | 5.2 |
| 229.7 | 3,569.8 | 1,041.9 | 96.4 | 12.0 | 11.5 | 36.9 | 3.1 | |
| 638.2 | 33,250.4 | 4,461.2 | 397.5 | 13.4 | 9.1 | 101.7 | 7.2 | |
| 418.5 | 13,396.2 | 1,976.2 | 160.7 | 14.1 | 6.7 | 106.3 | 6.8 | |
| 4,754.1 | 2,304.8 | 450.7 | 69.9 | 22.1 | 26.7 | 33 | 6.9 | |
| 553.4 | 8,257.2 | 2,478.2 | 24.7 | 8.4 | 4.2 | 435.7 | 6.2 | |
| 1,282.4 | 8,196.1 | 1,433.4 | 188.7 | 17.4 | 13.8 | 43.5 | 5.5 | |
| 5,259.7 | 5,726.8 | 1,529.9 | 235.8 | 21.2 | 20.7 | 24.3 | 4.6 | |
| 1,110.4 | 11,273.6 | 1,613.3 | 259.9 | 23.0 | 17.3 | 43.8 | 7.1 | |
| 661.1 | 6,370.5 | 1,089.4 | 165.1 | 17.4 | 10.2 | 38.1 | 3.7 |
No Review & Analysis are available.
Indraprastha Medical Corporation Limited provides hospital services in India. The company offers services primarily in the areas of sugar, genomic medicine, elder care, anesthesiology, bariatric and metabolic surgery, bone marrow transplant, dental... and cosmetic clinic, dermatology, dietetics and clinical nutrition, vascular and endovascular surgery, endocrinology, ENT, fetal medicine, general and laparoscopic surgery, gynecology and obstetrics, hyperbaric oxygen therapy, IVF, neonatology, nephrology, nuclear medicine, ophthalmology, pediatric sciences, urology, and plastic surgery, as well as pediatric urology and surgery, physiotherapy and rehabilitation, psychiatry and clinical psychology, radiology and radio diagnosis, respiratory, rheumatology, spine surgery, urology and andrology, cardiology, oncology, emergency, gastroenterology, neuroscience, critical care, orthopedics, robotic surgery, and organ transplant, as well as laboratory services, interventional medicine, preventive medicine, and sleep medicine. Indraprastha Medical Corporation Limited was founded in 1983 and is based in New Delhi, India. Read more
Incorporated
1988
Chairman
--
Managing Director
Shivakumar Pattabhiraman
Group
Apollo Hospitals
Headquarters
New Delhi, Delhi
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Indraprastha Medical Corporation Ltd is ₹393.15 (NSE) and ₹393.55 (BSE) as of 19-Mar-2026 11:49 IST. Indraprastha Medical Corporation Ltd has given a return of 70.09% in the last 3 years.
The P/E ratio of Indraprastha Medical Corporation Ltd is 19.81 times as on 19-Mar-2026, a 55 discount to its peers’ median range of 44.50 times.
The P/B ratio of Indraprastha Medical Corporation Ltd is 5.18 times as on 19-Mar-2026, a 22 discount to its peers’ median range of 6.63 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
21.98
|
5.93
|
|
2024
|
12.70
|
3.30
|
|
2023
|
8.27
|
1.88
|
|
2022
|
9.14
|
1.65
|
|
2021
|
211.45
|
1.81
|
The 52-week high and low of Indraprastha Medical Corporation Ltd are Rs 640.85 and Rs 321.95 as of 19-Mar-2026.
Indraprastha Medical Corporation Ltd has a market capitalisation of ₹ 3,623 Cr as on 19-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Indraprastha Medical Corporation Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.